Genetic and antigenic characterization of a serotype P[6]G9 human rotavirus strain isolated in the United States

被引:25
作者
Kirkwood, CD
Gentsch, JR
Hoshino, Y
Clark, HF
Glass, RI
机构
[1] Ctr Dis Control & Prevent, Viral Gastroenteritis Sect, Resp & Enter Viruses Branch, Div Viral & Rickettsial Dis,Natl Ctr Infect Dis, Atlanta, GA 30333 USA
[2] NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA
[3] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
关键词
D O I
10.1006/viro.1998.9591
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
During an epidemiologic survey of rotavirus infections established to monitor the prevalent G serotypes circulating in the United States, human P[6]G9, subgroup I rotavirus strains causing symptomatic infections were identified as the fourth most common serotype. In this report we describe the molecular and antigenic characterization of one of these P[6]G9 isolates (US1205). Neutralization and sequencing studies have demonstrated that both outer capsid proteins, VP7 and VP4, of US1205 are closely related to but genetically and antigenically distinguishable from those of standard G9 strains (e.g., F45, WI61) and standard P2A[6] strains (e.g., ST3, M37). Thus the complete antigenic type of US1205 is P2A[6]G9, subgroup I. Sequence analysis of the VP6 and NSP4 genes of US1205;indicates that strain US1205 possessed VP6 subgroup I and NSP4A genotype specificities. Finally, Northern hybridization studies suggest that the P[6]G9 strains are closely related to members of the DS-I genogroup except for their P[6] VP4 gene, which has been commonly identified in strains of both major human genogroups, and their G9 VP7 gene, which may have been derived by reassortment with a Wa genogroup strain. Examination of historic collections and prospective surveillance of strains will he needed to determine whether this strain has been present for some time or if it is emerging to compete with the other common serotypes of rotavirus, (C) 1999 Academic Press.
引用
收藏
页码:45 / 53
页数:9
相关论文
共 43 条
[1]   EVALUATION OF RHESUS ROTAVIRUS MONOVALENT AND TETRAVALENT REASSORTANT VACCINES IN US CHILDREN [J].
BERNSTEIN, DI ;
GLASS, RI ;
RODGERS, G ;
DAVIDSON, BL ;
SACK, DA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (15) :1191-1196
[2]   SPECIFIC INTERACTIONS BETWEEN ROTAVIRUS OUTER CAPSID PROTEINS VP4 AND VP7 DETERMINE EXPRESSION OF A CROSS-REACTIVE, NEUTRALIZING VP4-SPECIFIC EPITOPE [J].
CHEN, DY ;
ESTES, MK ;
RAMIG, RF .
JOURNAL OF VIROLOGY, 1992, 66 (01) :432-439
[3]   ROTAVIRUS ISOLATE WI61 REPRESENTING A PRESUMPTIVE NEW HUMAN SEROTYPE [J].
CLARK, HF ;
HOSHINO, Y ;
BELL, LM ;
GROFF, J ;
HESS, G ;
BACHMAN, P ;
OFFIT, PA .
JOURNAL OF CLINICAL MICROBIOLOGY, 1987, 25 (09) :1757-1762
[4]   NEUTRALIZING MONOCLONAL-ANTIBODIES TO HUMAN ROTAVIRUS AND INDICATIONS OF ANTIGENIC DRIFT AMONG STRAINS FROM NEONATES [J].
COULSON, BS ;
FOWLER, KJ ;
BISHOP, RF ;
COTTON, RGH .
JOURNAL OF VIROLOGY, 1985, 54 (01) :14-20
[5]  
Cunliffe NA, 1997, J MED VIROL, V53, P41, DOI 10.1002/(SICI)1096-9071(199709)53:1<41::AID-JMV8>3.3.CO
[6]  
2-N
[7]  
CUNLIFFE NA, 1999, IN PRESS J MED VIROL, V57
[8]   CHARACTERIZATION OF THE G-SEROTYPE AND GENOGROUP OF NEW-DELHI NEWBORN ROTAVIRUS STRAIN-116E [J].
DAS, BK ;
GENTSCH, JR ;
HOSHINO, Y ;
ISHIDA, SI ;
NAKAGOMI, O ;
BHAN, MK ;
KUMAR, R ;
GLASS, RI .
VIROLOGY, 1993, 197 (01) :99-107
[9]   A COMPREHENSIVE SET OF SEQUENCE-ANALYSIS PROGRAMS FOR THE VAX [J].
DEVEREUX, J ;
HAEBERLI, P ;
SMITHIES, O .
NUCLEIC ACIDS RESEARCH, 1984, 12 (01) :387-395
[10]   COMPARISON OF VP4 AND VP7 OF 5 MURINE ROTAVIRUS STRAINS [J].
DUNN, SJ ;
BURNS, JW ;
CROSS, TL ;
VO, PT ;
WARD, RL ;
BREMONT, M ;
GREENBERG, HB .
VIROLOGY, 1994, 203 (02) :250-259